AYTU BIOPHARMA, INC Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
AYTU BIOPHARMA, INC (AYTU) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $273.00 thousand for the 12-month period ending 2022-06-30, per its 10-K filed 2023-10-12.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2023-10-12
- AYTU BIOPHARMA, INC effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $273.00K, a 534.88% increase from fiscal 2021.
- AYTU BIOPHARMA, INC effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2021 was $43.00K.
- AYTU BIOPHARMA, INC effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2020 was -$35.00K, a 1266.67% decline from fiscal 2019.
- AYTU BIOPHARMA, INC effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2019 was $3.00K, a 86.36% decline from fiscal 2018.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month as first filed |
|---|---|---|
| 2022-06-30 | $273.00K 10-K · filed 2023-10-12 | |
| 2021-06-30 | $43.00K 10-K · filed 2022-09-27 | |
| 2020-06-30 | -$35.00K 10-K · filed 2021-09-28 | |
| 2019-06-30 | $3.00K 10-K · filed 2020-10-06 | |
| 2018-06-30 | $22.00K 10-K · filed 2019-09-26 | |
| 2017-06-30 | $116.00K 10-K · filed 2018-09-06 | |
| 2016-06-30 | $7.00K 10-K · filed 2017-08-31 | $7.16K 10-K · filed 2016-09-01 |
| 2015-06-30 | $426.73K 10-K · filed 2016-09-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |